Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2018

Open Access 01-06-2018 | Research Article

Implementation fidelity of a clinical medication review intervention: process evaluation

Authors: F. Willeboordse, F. G. Schellevis, M. C. Meulendijk, J. G. Hugtenburg, P. J. M. Elders

Published in: International Journal of Clinical Pharmacy | Issue 3/2018

Login to get access

Abstract

Background Implementation of clinical medication reviews in daily practice is scarcely evaluated. The Opti-Med intervention applied a structured approach with external expert teams (pharmacist and physician) to conduct medication reviews. The intervention was effective with respect to resolving drug related problems, but did not improve quality of life. Objective The objective of this process evaluation was to gain more insight into the implementation fidelity of the intervention. Setting Process evaluation alongside a cluster randomized trial in 22 general practices and 518 patients of 65 years and over. Method A mixed methods design using quantitative and qualitative data and the conceptual framework for implementation fidelity was used. Implementation fidelity is defined as the degree to which the various components of an intervention are delivered as intended. Main outcome measure Implementation fidelity for key components of the Opti-Med intervention. Results Patient selection and preparation of the medication analyses were carried out as planned, although mostly by the Opti-Med researchers instead of practice nurses. Medication analyses by expert teams were performed as planned, as well as patient consultations and patient involvement. 48% of the proposed changes in the medication regime were implemented. Cooperation between expert teams members and the use of an online decision-support medication evaluation facilitated implementation. Barriers for implementation were time constraints in daily practice, software difficulties with patient selection and incompleteness of medical files. The degree of embedding of the intervention was found to influence implementation fidelity. The total time investment for healthcare professionals was 94 min per patient. Conclusion Overall, the implementation fidelity was moderate to high for all key components of the Opti-Med intervention. The absence of its effectiveness with respect to quality of life could not be explained by insufficient implementation fidelity.
Appendix
Available only for authorised users
Literature
3.
go back to reference Clyne W, Blenkinsopp A, Seal R. A guide to medication review. UK: NHS National Prescribing Centre; 2008. Clyne W, Blenkinsopp A, Seal R. A guide to medication review. UK: NHS National Prescribing Centre; 2008.
4.
go back to reference Cooper JA, Cadogan CA, Patterson SM, Kerse N, Bradley MC, Ryan C, et al. Interventions to improve the appropriate use of polypharmacy in older people: a cochrane systematic review. BMJ Open. 2015;5(12):e009235.CrossRefPubMedPubMedCentral Cooper JA, Cadogan CA, Patterson SM, Kerse N, Bradley MC, Ryan C, et al. Interventions to improve the appropriate use of polypharmacy in older people: a cochrane systematic review. BMJ Open. 2015;5(12):e009235.CrossRefPubMedPubMedCentral
5.
go back to reference NHS Cumbria Medicines Management Team. Clinical medication review: a practice guide. UK, 2013. NHS Cumbria Medicines Management Team. Clinical medication review: a practice guide. UK, 2013.
6.
go back to reference Pharmaceutical Society of Australia. Guidelines for pharmacists providing home medicines review (HMR) services. Australia, 2011. Pharmaceutical Society of Australia. Guidelines for pharmacists providing home medicines review (HMR) services. Australia, 2011.
7.
go back to reference Nederlands Huisarts Genootschap (NHG). Multidisciplinaire richtlijn Polyfarmacie bij ouderen. (Multidisciplinary guideline Polypharmacy for elderly). The Netherlands, 2012. Nederlands Huisarts Genootschap (NHG). Multidisciplinaire richtlijn Polyfarmacie bij ouderen. (Multidisciplinary guideline Polypharmacy for elderly). The Netherlands, 2012.
8.
go back to reference de Bruijne MC, Kemper PF, Bakker L, Heeren MJ, Meijler AP, Dolwel GO, et al. Farmacotherapeutische zorg voor voor kwetsbare ouderen met polyfarmacie (Pharmaceutical care for frail elderly with poypharmacy). Amsterdam, 2014. de Bruijne MC, Kemper PF, Bakker L, Heeren MJ, Meijler AP, Dolwel GO, et al. Farmacotherapeutische zorg voor voor kwetsbare ouderen met polyfarmacie (Pharmaceutical care for frail elderly with poypharmacy). Amsterdam, 2014.
9.
go back to reference Rosenthal M, Holmes E, Banahan B, III. Making MTM implementable and sustainable in community pharmacy: Is it time for a different game plan? Res Soc Adm Pharm. 2015. Rosenthal M, Holmes E, Banahan B, III. Making MTM implementable and sustainable in community pharmacy: Is it time for a different game plan? Res Soc Adm Pharm. 2015.
10.
go back to reference Clyne B, Fitzgerald C, Quinlan A, Hardy C, Galvin R, Fahey T, et al. Interventions to address potentially inappropriate prescribing in community-dwelling older adults: a systematic review of randomized controlled trials. J Am Geriatr Soc. 2016;64(6):1210–22.CrossRefPubMed Clyne B, Fitzgerald C, Quinlan A, Hardy C, Galvin R, Fahey T, et al. Interventions to address potentially inappropriate prescribing in community-dwelling older adults: a systematic review of randomized controlled trials. J Am Geriatr Soc. 2016;64(6):1210–22.CrossRefPubMed
11.
go back to reference Willeboordse F, Hugtenburg JG, van DL, Bosmans JE, de Vries OJ, Schellevis FG, et al. Opti-Med: the effectiveness of optimised clinical medication reviews in older people with ‘geriatric giants’ in general practice; study protocol of a cluster randomised controlled trial. BMC Geriatr. 2014;14:116.CrossRefPubMedPubMedCentral Willeboordse F, Hugtenburg JG, van DL, Bosmans JE, de Vries OJ, Schellevis FG, et al. Opti-Med: the effectiveness of optimised clinical medication reviews in older people with ‘geriatric giants’ in general practice; study protocol of a cluster randomised controlled trial. BMC Geriatr. 2014;14:116.CrossRefPubMedPubMedCentral
12.
go back to reference Willeboordse F, Schellevis FG, Chau SH, Hugtenburg JG, Elders PJ. The effectiveness of optimised clinical medication reviews for geriatric patients: opti-med a cluster randomised controlled trial. Fam Pract. 2017;34(4):437–45.CrossRefPubMed Willeboordse F, Schellevis FG, Chau SH, Hugtenburg JG, Elders PJ. The effectiveness of optimised clinical medication reviews for geriatric patients: opti-med a cluster randomised controlled trial. Fam Pract. 2017;34(4):437–45.CrossRefPubMed
13.
go back to reference Meulendijk MC, Spruit MR, Drenth-van Maanen AC, Numans ME, Brinkkemper S, Jansen PA, et al. Computerized decision support improves medication review effectiveness: an experiment evaluating the STRIP assistant’s usability. Drugs Aging. 2015;32(6):495–503.CrossRefPubMedPubMedCentral Meulendijk MC, Spruit MR, Drenth-van Maanen AC, Numans ME, Brinkkemper S, Jansen PA, et al. Computerized decision support improves medication review effectiveness: an experiment evaluating the STRIP assistant’s usability. Drugs Aging. 2015;32(6):495–503.CrossRefPubMedPubMedCentral
14.
go back to reference Chrischilles E, Rubenstein L, Van Gilder R, Voelker M, Wright K, Wallace R. Risk factors for adverse drug events in older adults with mobility limitations in the community setting. J Am Geriatr Soc. 2007;55(1):29–34.CrossRefPubMed Chrischilles E, Rubenstein L, Van Gilder R, Voelker M, Wright K, Wallace R. Risk factors for adverse drug events in older adults with mobility limitations in the community setting. J Am Geriatr Soc. 2007;55(1):29–34.CrossRefPubMed
15.
go back to reference Dros J, Maarsingh OR, Beem L, van der Horst HE, ter Riet G, Schellevis FG, et al. Functional prognosis of dizziness in older adults in primary care: a prospective cohort study. J Am Geriatr Soc. 2012;60(12):2263–9.CrossRefPubMed Dros J, Maarsingh OR, Beem L, van der Horst HE, ter Riet G, Schellevis FG, et al. Functional prognosis of dizziness in older adults in primary care: a prospective cohort study. J Am Geriatr Soc. 2012;60(12):2263–9.CrossRefPubMed
16.
go back to reference Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med. 1987;107(2):169–73.CrossRefPubMed Larson EB, Kukull WA, Buchner D, Reifler BV. Adverse drug reactions associated with global cognitive impairment in elderly persons. Ann Intern Med. 1987;107(2):169–73.CrossRefPubMed
17.
go back to reference Ruby CM, Hanlon JT, Boudreau RM, Newman AB, Simonsick EM, Shorr RI, et al. The effect of medication use on urinary incontinence in community-dwelling elderly women. J Am Geriatr Soc. 2010;58(9):1715–20.CrossRefPubMedPubMedCentral Ruby CM, Hanlon JT, Boudreau RM, Newman AB, Simonsick EM, Shorr RI, et al. The effect of medication use on urinary incontinence in community-dwelling elderly women. J Am Geriatr Soc. 2010;58(9):1715–20.CrossRefPubMedPubMedCentral
18.
go back to reference Tinetti ME, Inouye SK, Gill TM, Doucette JT. Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA. 1995;273(17):1348–53.CrossRefPubMed Tinetti ME, Inouye SK, Gill TM, Doucette JT. Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA. 1995;273(17):1348–53.CrossRefPubMed
19.
go back to reference Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952–60.CrossRefPubMed Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952–60.CrossRefPubMed
20.
go back to reference Willeboordse F, Grundeken LH, van den Eijkel LP, Schellevis FG, Elders PJ, Hugtenburg JG. Information on actual medication use and drug-related problems in older patients: questionnaire or interview? Int J Clin Pharm. 2016;38(2):380–7.CrossRefPubMedPubMedCentral Willeboordse F, Grundeken LH, van den Eijkel LP, Schellevis FG, Elders PJ, Hugtenburg JG. Information on actual medication use and drug-related problems in older patients: questionnaire or interview? Int J Clin Pharm. 2016;38(2):380–7.CrossRefPubMedPubMedCentral
21.
go back to reference Williams M, Peterson GM, Tenni PC, Bindoff IK, Stafford AC. DOCUMENT: a system for classifying drug-related problems in community pharmacy. Int J Clin Pharm. 2012;34(1):43–52.CrossRefPubMed Williams M, Peterson GM, Tenni PC, Bindoff IK, Stafford AC. DOCUMENT: a system for classifying drug-related problems in community pharmacy. Int J Clin Pharm. 2012;34(1):43–52.CrossRefPubMed
22.
go back to reference Atlas.ti version 7.5.16 Gmbh [Computer software]. Berlin. Atlas.ti version 7.5.16 Gmbh [Computer software]. Berlin.
23.
go back to reference Allard J, Hebert R, Rioux M, Asselin J, Voyer L. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ. 2001;164(9):1291–6.PubMedPubMedCentral Allard J, Hebert R, Rioux M, Asselin J, Voyer L. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ. 2001;164(9):1291–6.PubMedPubMedCentral
24.
go back to reference Clyne B, Cooper JA, Hughes CM, Fahey T, Smith SM, Team O-Ss. A process evaluation of a cluster randomised trial to reduce potentially inappropriate prescribing in older people in primary care (OPTI-SCRIPT study). Trials. 2016;17(1):386.CrossRefPubMedPubMedCentral Clyne B, Cooper JA, Hughes CM, Fahey T, Smith SM, Team O-Ss. A process evaluation of a cluster randomised trial to reduce potentially inappropriate prescribing in older people in primary care (OPTI-SCRIPT study). Trials. 2016;17(1):386.CrossRefPubMedPubMedCentral
25.
go back to reference Kwint HF, Bermingham L, Faber A, Gussekloo J, Bouvy ML. The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review. Drugs Aging. 2013;30(2):91–102.CrossRefPubMed Kwint HF, Bermingham L, Faber A, Gussekloo J, Bouvy ML. The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review. Drugs Aging. 2013;30(2):91–102.CrossRefPubMed
26.
go back to reference Chau SH, Jansen AP, van de Ven PM, Hoogland P, Elders PJ, Hugtenburg JG. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands. Int J Clin Pharm. 2016;38(1):46–53.CrossRefPubMed Chau SH, Jansen AP, van de Ven PM, Hoogland P, Elders PJ, Hugtenburg JG. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands. Int J Clin Pharm. 2016;38(1):46–53.CrossRefPubMed
27.
go back to reference Mast RM, Schouten GP, van Woerkom M. Niveau van medicatiebeoordeling initiatieven in Nederland kan beter. (Room for improvement in medication review initiatives in the Netherlands). Pharm Weekbl Sci. 2010;4(11/12):189–94. Mast RM, Schouten GP, van Woerkom M. Niveau van medicatiebeoordeling initiatieven in Nederland kan beter. (Room for improvement in medication review initiatives in the Netherlands). Pharm Weekbl Sci. 2010;4(11/12):189–94.
28.
go back to reference Meulendijk MC, Spruit MR, Willeboordse F, Numans ME, Brinkkemper S, Knol W, et al. Efficiency of clinical decision support systems improves with experience. J Med Syst. 2016;40(4):76.CrossRefPubMedPubMedCentral Meulendijk MC, Spruit MR, Willeboordse F, Numans ME, Brinkkemper S, Knol W, et al. Efficiency of clinical decision support systems improves with experience. J Med Syst. 2016;40(4):76.CrossRefPubMedPubMedCentral
29.
go back to reference Sinnige J, Korevaar JC, van LJ, Westert GP, Schellevis FG, Braspenning JC. Medication management strategy for older people with polypharmacy in general practice: a qualitative study on prescribing behaviour in primary care. Br J Gen Pract. 2016;66(649):e540–51.CrossRefPubMedPubMedCentral Sinnige J, Korevaar JC, van LJ, Westert GP, Schellevis FG, Braspenning JC. Medication management strategy for older people with polypharmacy in general practice: a qualitative study on prescribing behaviour in primary care. Br J Gen Pract. 2016;66(649):e540–51.CrossRefPubMedPubMedCentral
30.
go back to reference Reeve E, Andrews JM, Wiese MD, Hendrix I, Roberts MS, Shakib S. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Ann Pharmacother. 2015;49(1):29–38.CrossRefPubMed Reeve E, Andrews JM, Wiese MD, Hendrix I, Roberts MS, Shakib S. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Ann Pharmacother. 2015;49(1):29–38.CrossRefPubMed
Metadata
Title
Implementation fidelity of a clinical medication review intervention: process evaluation
Authors
F. Willeboordse
F. G. Schellevis
M. C. Meulendijk
J. G. Hugtenburg
P. J. M. Elders
Publication date
01-06-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 3/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0615-y

Other articles of this Issue 3/2018

International Journal of Clinical Pharmacy 3/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.